MAPK1 and breast carcinoma: Since the PI3K/Akt and MEK/ERK pathways are highly interconnected, and their dual targeting was shown to significantly enhance antitumor activity in breast cancer [96], we evaluated the effect of AUT treatment on ERK activity.